Login

Furiex Pharmaceuticals, Inc. SEC Filings

Filed On Filing
17 Feb 2015 SC 13G/A
17 Feb 2015 CONSONANCE CAPITAL MANAGEMENT LP
06 Feb 2015 SCHEDULE 13G
14 Jul 2014 FORM 15
09 Jul 2014 SCHEDULE 13D AMENDMENT NO. 1
07 Jul 2014 EFFECT
07 Jul 2014 Form 4: Forest Laboratories, Llc, 10% owner and 1 other

Bought 11,169,066 shares ($1.06B)

07 Jul 2014 SC 13D
07 Jul 2014 Form 4: Eshelman Fredric N, Director

Returned 2,848,017 shares to the issuer · Disposed of 164,689 Stock Options (to buy) (Disposition to Issuer)

07 Jul 2014 Form 4: McIntyre Gail Frances, Senior Vice President-Research

Returned 24,318 shares to the issuer · Disposed of 59,350 Stock Options (to buy) (Disposition to Issuer)

07 Jul 2014 Form 4: Covington Paul S, Senior VP-Clinical Operations

Returned 22,523 shares to the issuer · Disposed of 63,944 Stock Options (to buy) (Disposition to Issuer)

07 Jul 2014 Form 4: Dixon Wendy L, Director

Returned 7,160 shares to the issuer · Disposed of 52,570 Stock Options (to buy) (Disposition to Issuer)

07 Jul 2014 Form 4: Patel Sailash, Chief Financial Officer

Returned 26,444 shares to the issuer · Disposed of 84,298 Stock Options (to buy) (Disposition to Issuer)

07 Jul 2014 Form 4: Corr Peter B, Director

Returned 8,447 shares to the issuer · Disposed of 40,470 Stock Options (to buy) (Disposition to Issuer)

07 Jul 2014 Form 4: Almenoff June Sherie, Director

Returned 24,600 shares to the issuer · Disposed of 138,882 Stock Options (to buy) (Disposition to Issuer)

07 Jul 2014 Form 4: Kaldor Stephen W, Director

Returned 7,160 shares to the issuer · Disposed of 31,337 Stock Options (to buy) (Disposition to Issuer)

07 Jul 2014 Form 4: Davis Stephen, Director

Returned 9,308 shares to the issuer

03 Jul 2014 SCHEDULE 13D/A
03 Jul 2014 8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +5 more
02 Jul 2014 S-8 POS

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support